Literature DB >> 16556510

Patients supported for over 4 years with left ventricular assist devices.

Evgenij V Potapov1, Michael J Jurmann, Thorsten Drews, Miralem Pasic, Matthias Loebe, Yuguo Weng, Roland Hetzer.   

Abstract

Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in patients who are not candidates for heart transplantation. This study presents our institution's experience with five patients successfully supported by two different left ventricular assist devices for over 4 years. This unique experience shows that left ventricular assist device support can be extended beyond 4 years with good quality of life and low risk, making it a good alternative for non-transplant candidates.

Entities:  

Mesh:

Year:  2006        PMID: 16556510     DOI: 10.1016/j.ejheart.2006.02.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  6 in total

1.  Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device.

Authors:  Felix Hennig; Alexander V Stepanenko; Hans B Lehmkuhl; Marian Kukucka; Michael Dandel; Thomas Krabatsch; Roland Hetzer; Evgenij V Potapov
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

Review 2.  LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant.

Authors:  Anne K Eshelman; Shawn Mason; Hassan Nemeh; Celeste Williams
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

3.  Fully printed prothrombin time sensor for point-of-care testing.

Authors:  Nicholas X Williams; Brittani Carroll; Steven G Noyce; Hansel Alex Hobbie; Daniel Y Joh; Joseph G Rogers; Aaron D Franklin
Journal:  Biosens Bioelectron       Date:  2020-10-26       Impact factor: 10.618

4.  Anticoagulant monitoring in ventricular assist device patients: a feasibility study.

Authors:  Ashish Joshi; Diane Smith; Mohit Arora; Robert Poston
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-09-04

Review 5.  Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?

Authors:  Massimo Bonacchi; Guy Harmelin; Marco Bugetti; Guido Sani
Journal:  Front Surg       Date:  2015-08-03

Review 6.  Heart failure and mechanical circulatory assist devices.

Authors:  Eluisa La Franca; Rosanna Iacona; Laura Ajello; Angela Sansone; Marco Caruso; Pasquale Assennato
Journal:  Glob J Health Sci       Date:  2013-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.